AArkstore enterprise 5th December 2014
Skin and Skin Structure Infections (SSSI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Browse Full Report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60349/skin-and-skin-structureinfections-sssi-therapeutics-pipeline-assessment-and-market-forecasts Published: Feb 2012 | No. Of Pages: 79 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
Summary The industry analysis specialist, has released its new report, “Skin and Skin Structure Infections (SSSI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Skin and Skin Structure Infections Therapeutics market. The report identifies the key trends shaping and driving the global Skin and Skin Structure Infections Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Skin and Skin Structure Infections Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope The report provides information on the key drivers and challenges of the Skin and Skin Structure Infections Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Skin and Skin Structure Infections Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
Website : http://www.aarkstore.com/
AArkstore enterprise - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Skin and Skin Structure Infections Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Skin and Skin Structure Infections Therapeutics market. - Analysis of key recent licensing and partnership agreements in Skin and Skin Structure Infections Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Skin and Skin Structure Infections Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Skin and Skin Structure Infections Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Skin and Skin Structure Infections Therapeutics market landscape? – Identify, understand and capitalize.
Website : http://www.aarkstore.com/
AArkstore enterprise
Special Discount on Global Data Market Research Reports: Click here an avail Discount offer on Global Data market research reports: http://www.aarkstore.com/discount.php Discount Valid till 31st December 2014 For Research Reports Call us on: +91 9987295242 OR Mail us at contact@aarkstore.com
Tables Of Contents 2 Skin and Skin Structure Infections Therapeutics - Introduction 2.1 Overview 2.2 Pathophysiology 2.3 Epidemiology 2.4 Etiology 2.5 Symptoms
Website : http://www.aarkstore.com/
AArkstore enterprise 2.6 Diagnosis 2.7 Treatment and Management Pattern 2.8 GlobalData Report Guidance 3 Skin and Skin Structure Infections Therapeutics - Market Characterization 3.1 Skin and Skin Structure Infections Therapeutics Global Market Size (2006-2011) 3.2 Skin and Skin Structure Infections Therapeutics Global Market Forecast (2011-2019) 3.3 Skin and Skin Structure Infections Therapeutics Market (2006-2011) - The US 3.4 Skin and Skin Structure Infections Therapeutics Market Forecast (2011-2019) - The US 3.5 Skin and Skin Structure Infections Therapeutics Market (2006-2011) - France 3.6 Skin and Skin Structure Infections Therapeutics Market Forecast (2011-2019) - France 3.7 Skin and Skin Structure Infections Therapeutics Market (2006-2011) - Germany 3.8 Skin and Skin Structure Infections Therapeutics Market Forecast (2011-2019) - Germany 3.9 Skin and Skin Structure Infections Therapeutics Market (2006-2011) - Spain 3.10 Skin and Skin Structure Infections Therapeutics Market Forecast (2011-2019) - Spain 3.11 Skin and Skin Structure Infections Therapeutics Market (2006-2011) - Italy 3.12 Skin and Skin Structure Infections Therapeutics Market Forecast (2011-2019) - Italy 3.13 Skin and Skin Structure Infections Therapeutics Market (2006-2011) - The UK 3.14 Skin and Skin Structure Infections Therapeutics Market Forecast (2011-2019) - The UK 3.15 Skin and Skin Structure Infections Therapeutics Market (2006-2011) - Japan 3.16 Skin and Skin Structure Infections Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Skin and Skin Structure Infections Therapeutics Market 3.17.1 Skin and Skin Structure Infections Therapeutics Market Drivers 3.17.2 Skin and Skin Structure Infections Therapeutics Market Barriers
Website : http://www.aarkstore.com/
AArkstore enterprise 3.18 Opportunity and Unmet Need 3.19 Key Takeaway 4 Skin and Skin Structure Infections Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles of the Major Market Products in the Skin and Skin Structure Infections Therapeutics Market 4.3.1 Vancomycin 4.3.2 Zyvox (linezolid) 4.3.3 Cubicin (daptomycin) 4.3.4 Vibativ (telavancin) 4.3.5 Tygacil (tigecycline) 4.3.6 Avelox (Moxifloxacin hydrochloride) 4.3.7 Zosyn (piperacillin/tazobactam) 4.3.8 Teflaro (Ceftaroline) 4.4 Skin and Skin Structure Infections Therapeutics - Comparison of Major Marketed Products 4.5 Key Takeaway 5 Skin and Skin Structure Infections Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Skin and Skin Structure Infections Therapeutics Market - Pipeline Assessment by Phase of Development 5.3.1 Skin and Skin Structure Infections Therapeutics Market - Phase III Pipeline 5.3.2 Skin and Skin Structure Infections Therapeutics Market - Phase II Pipeline 5.3.3 Skin and Skin Structure Infections Therapeutics Market - Phase I Clinical Pipeline
Website : http://www.aarkstore.com/
AArkstore enterprise 5.3.4 Skin and Skin Structure Infections Therapeutics Market - Preclinical Pipeline 5.3.5 Skin and Skin Structure Infections Therapeutics Market - Discovery Pipeline 5.4 Skin and Skin Structure Infections Therapeutics - Pipeline by Mechanism of Action 5.5 Technology Trends Analytical Framework 5.6 Skin and Skin Structure Infections Therapeutics Market - Most Promising Drugs under Clinical Development 5.7 Most Promising Drug Profiles 5.7.1 Torezolid phosphate (TR-701, DA-7218) 5.8 Late Stage Molecules under FDA Review 5.9 Key Takeaway 6 Skin and Skin Structure Infections Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Prominent Sponsors 6.5 Brief Profiles of Top Ten Companies Participating in Therapeutics Clinical Trials 7 Skin and Skin Structure Infections Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Skin and Skin Structure Infections Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Takeda Pharmaceutical Company Limited 8.2.2 Basilea Pharmaceuticals
Website : http://www.aarkstore.com/
AArkstore enterprise 8.2.3 Forest Laboratories 8.2.4 Novartis AG. 8.2.5 Trius Therapeutics, Inc. 8.2.6 The Medicines Company 8.2.7 Biosynexus Incorporated 8.2.8 AstraZeneca PLC 8.2.9 GlaxoSmithKline plc 8.2.10 e-Therapeutics plc 8.2.11 Rib-X Pharmaceuticals, Inc 8.2.12 Key Takeaway 9 Skin and Skin Structure Infections Therapeutics - Licensing & Partnership Deals 10 Skin and Skin Structure Infections Therapeutics - Appendix 10.1 Market Definitions 10.2 Acronyms 10.3 Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
Website : http://www.aarkstore.com/
AArkstore enterprise List Of Tables Table 1: Skin and Skin Structure Infections Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 2: Skin and Skin Structure Infections Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 3: Skin and Skin Structure Infections Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 4: Skin and Skin Structure Infections Therapeutics, Major Market, The US, Forecast ($m), 2011-2019 Table 5: Skin and Skin Structure Infections Therapeutics, France, Revenue ($m), 2006-2011 Table 6: Skin and Skin Structure Infections Therapeutics Market, France, Forecast ($m), 2011-2019 Table 7: Skin and Skin Structure Infections Therapeutics, Germany, Revenue ($m), 2006-2011 Table 8: Skin and Skin Structure Infections Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 9: Skin and Skin Structure Infections Therapeutics, Spain, Revenue ($m), 2006-2011 Table 10: Skin and Skin Structure Infections Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 11: Skin and Skin Structure Infections Therapeutics, Italy, Revenue ($m), 2006-2011 Table 12: Skin and Skin Structure Infections Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 13: Skin and Skin Structure Infections Therapeutics, The UK, Revenue ($m), 2006-2011 Table 14: Skin and Skin Structure Infections Therapeutics, Major Market, The UK, Forecast ($m), 2011-2019 Table 15: Skin and Skin Structure Infections Therapeutics, Japan, Revenue ($m), 2006-2011 Table 16: Skin and Skin Structure Infections Therapeutics, Major Market, Japan, Forecast ($m), 2011-2019 Table 17: Comparison of Major Marketed Products Comparison in Skin and Skin Structure Infections Therapeutics Market, 2011 Table 18: Skin and Skin Structure Infections Therapeutics - Phase III Pipeline, 2011 Table 19: Skin and Skin Structure Infections Therapeutics - Phase II Pipeline, 2011 Table 20: Skin and Skin Structure Infections Therapeutics - Phase I Pipeline, 2011 Table 21: Skin and Skin Structure Infections Therapeutics - Preclinical Pipeline, 2011
Website : http://www.aarkstore.com/
AArkstore enterprise Table 22: Skin and Skin Structure Infections Therapeutics - Discovery Pipeline, 2011 Table 23: Skin and Skin Structure Infections Therapeutics Market - Most Promising Drugs Under Clinical Development, 2011 Table 24: Comparison of linezolid and torezolid Table 25: Development Status of Ceftobiprole Table 26: Development status of Dalbavancin Table 27: Development Status of Iclaprim Table 28: Skin and Skin Structure Infections Therapeutics - Clinical Trials by Country, 2011 Table 29: Skin and Skin Structure Infections Therapeutics, Major Markets - Clinical Trials by Phase, 2011 Table 30: Skin and Skin Structure Infections Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 Table 31: Skin and Skin Structure Infections Therapeutics, Major Markets, Prominent Sponsors, 2011 Table 32: Skin and Skin Structure Infections Therapeutics Market, Global, Clinical Trials by Lead Sponsors, 2011 Table 33: Takeda Pipeline Products 2011 Table 34: Basilea Pipeline Products 2011 Table 35: Forest Pipeline Products 2011 Table 36: Pipeline Molecules 2011 Table 37: The Medicine Company Pipeline Products 2011 Table 38: The Medicine Company Pipeline Products 2011 Table 39: AstraZeneca Pipeline Products 2011 Table 40: GlaxoSmithKline Pipeline Products 2011 Table 41: e-Therapeutics Pipeline Products 2011 Table 42: GlaxoSmithKline Pipeline Products 2011 Table 43: Licensing and Partnership Deals
Website : http://www.aarkstore.com/
AArkstore enterprise List Of Figures Figure 1: Treatment and Management Pattern for Inpatients and Outpatients SSSI Figure 2: Treatment and Management Pattern for SSSI Figure 3: Skin and Skin Structure Infections Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 4: Skin and Skin Structure Infections Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 5: Skin and Skin Structure Infections Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 6: Skin and Skin Structure Infections Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 7: Skin and Skin Structure Infections Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 8: Skin and Skin Structure Infections Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 9: Skin and Skin Structure Infections Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 10: Skin and Skin Structure Infections Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 11: Skin and Skin Structure Infections Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 12: Skin and Skin Structure Infections Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 13: Skin and Skin Structure Infections Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 14: Skin and Skin Structure Infections Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 15: Skin and Skin Structure Infections Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 16: Skin and Skin Structure Infections Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 17: Skin and Skin Structure Infections Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 18: Skin and Skin Structure Infections Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 19: Opportunity and Unmet Need in the Skin and Skin Structure Infections Therapeutics Market Figure 20: Strategic Competitor Assessment Figure 21: Skin and Skin Structure Infections Therapeutics - Clinical Pipeline by Mechanism of Action, 2011 Figure 22: Skin and Skin Structure Infections Therapeutics Market - Pipeline by Phase of Development, 2011
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 23: Technology Trends Analytics Framework, 2011 Figure 24: Technology Trends Analytics Framework - Description, 2011 Figure 25: Skin and Skin Structure Infections Therapeutics - Clinical Trials by Country, 2011 Figure 26: Skin and Skin Structure Infections Therapeutics, Major Markets - Clinical Trials by Phase, 2011 Figure 27: Skin and Skin Structure Infections Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 Figure 28: Skin and Skin Structure Infections Therapeutics, Major Markets, Prominent Sponsors, 2011 Figure 29: Skin and Skin Structure Infections Therapeutics, Major Markets, Clinical Trials of Top 10 Companies by Phase, 2011 Figure 30: Skin and Skin Structure Infections Therapeutics Market, Drivers and Restraints 2011 Figure 31: Implications for Future Market Competition in the Skin and Skin Structure Infections Therapeutics Market, 2011 Figure 32: Skin and Skin Structure Infections Therapeutics Market - Clinical Pipeline by Company, 2011 Figure 33: GlobalData Market Forecasting Model
Discount Reports: Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019 Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Website : http://www.aarkstore.com/
AArkstore enterprise Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018 Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018
About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60349/skin-and-skinstructure-infections-sssi-therapeutics-pipeline-assessment-and-market-forecasts
Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com Facebook: https://www.facebook.com/aarkstoredotcom Linkedin: http://www.linkedin.com/company/aarkstore-enterprise
Website : http://www.aarkstore.com/
AArkstore enterprise
Website : http://www.aarkstore.com/